Aerie Pharma (AERI) PT Lowered to $30 at Cowen as CEO Steps Down
Tweet Send to a Friend
Cowen analyst Ken Cacciatore lowered the price target on Aerie Pharma (NASDAQ: AERI) to $30.00 (from $50.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
